Avantor Shares Down After 4Q Earnings, Sales Drop

Dow Jones
Feb 11
 

By Rob Curran

 

Shares of life-sciences firm Avantor slid premarket after the company logged lower fourth-quarter net income and sales, and said 2026 would mark a transitional phase of a long-term turnaround plan.

The Radnor, Pa., provider of specialized chemicals and equipment to laboratories, posted earnings of $52.4 million, or 8 cents a share, down sharply from $500.4 million, or 73 cents a share, a year earlier. Analysts, on average, had anticipated earnings of 12 cents a share.

Stripping out certain one-off items, Avantor posted adjusted earnings of 22 cents a share, in line with the average Wall Street peg, as per FactSet.

Sales fell 1% to $1.66 billion.

Shares slid 11% to $9.88 premarket.

Avantor has recently launched a turnaround plan, dubbed Revival.

"We are moving with urgency to execute Revival and turn around the performance of this great business," said President and Chief Executive Emmanuel Ligner, in a statement. "2026 will be a year of transition and purposeful investment, and our priority is driving top line growth by competing vigorously in the marketplace and strengthening our company."

Shares had taken a beating in November after Avantor posted a third-quarter loss due to a charge.

 

Write to Rob Curran at rob.curran@dowjones.com

 

(END) Dow Jones Newswires

February 11, 2026 08:07 ET (13:07 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10